Krystal Biotech Inc. (KRYS)
NASDAQ: KRYS
· Real-Time Price · USD
130.19
-2.85 (-2.15%)
At close: Jun 17, 2025, 3:59 PM
129.50
-0.53%
After-hours: Jun 17, 2025, 07:25 PM EDT
-2.15% (1D)
| Bid | 129.5 |
| Market Cap | 3.76B |
| Revenue (ttm) | 333.45M |
| Net Income (ttm) | 123.96M |
| EPS (ttm) | 4.17 |
| PE Ratio (ttm) | 31.22 |
| Forward PE | 15.27 |
| Analyst | Buy |
| Ask | 130.67 |
| Volume | 309,501 |
| Avg. Volume (20D) | 346,620 |
| Open | 130.75 |
| Previous Close | 133.04 |
| Day's Range | 129.19 - 132.91 |
| 52-Week Range | 122.80 - 219.34 |
| Beta | 0.66 |
About KRYS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KRYS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KRYS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-14.06%
Krystal Biotech shares are trading lower after the...
Unlock content with
Pro Subscription
3 months ago
+3.66%
Krystal Biotech shares are trading higher after Chardan Capital raised its price target on the stock from $212 to $218.
2 months ago · seekingalpha.com
Krystal Biotech: Preparing To Chase Following Positive CHMP Opinion For VYJUVEKKrystal Biotech's VYJUVEK, a first-mover gene therapy for DEB, has received a positive CHMP recommendation, potentially boosting its global market presence and valuation. Despite KRYS's premium valuat...
